Potentially Inappropriate Medications (PIMs) in Elderly Hypertensive Inpatients using 2023 AGS Beers Criteria: A Cross-Sectional Study Prevalence and predictors of PIM exposure among elderly inpatients
Main Article Content
Abstract
Polypharmacy and complex pharmacotherapy are common in older adults with hypertension and increase the risk of potentially inappropriate medications (PIMs). This study aimed to determine the prevalence, pattern, and predictors of PIM exposure among elderly hypertensive inpatients at Universitas Indonesia Hospital (RSUI) using the American Geriatrics Society 2023 updated AGS Beers Criteria®. A retrospective cross-sectional study was conducted using de-identified electronic medical records. From 1,265 admissions screened in 2023-2024, 200 hypertensive inpatients aged 65 years or older were included. Inpatient prescriptions were evaluated using the 2023 AGS Beers Criteria and classified by Beers categories. Logistic regression was used to identify predictors of PIM exposure. The mean age was 72.1 ± 6.5 years, and 55.0% were female; polypharmacy (≥5 medications) occurred in 85.5%. Overall, 83.0% received at least one Beers-listed medicine, most commonly Category 3 (“use with caution”) PIMs (72.5%), followed by Category 1 (“avoid”) (26.0%) and Category 4 (23.0%). Diuretics (furosemide, hydrochlorothiazide) and clonidine were frequent PIM-related medications. Polypharmacy was the only significant independent predictor of PIM exposure. These findings support systematic medication review and deprescribing-focused interventions during hospitalization.
Article Details
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The authors retain the copyright and grant the journal the right of first publication simultaneously under the Creative Commons Attribution License. This license allows others to share the work with proper acknowledgment of authorship and initial publication in this journal. Authors are permitted and encouraged to deposit their articles in institutional repositories, on their personal websites, or in other online repositories after the article has been published in JSFK.
References
[1] Zhao J, Hu Y, Zhang X, Zhang G, Lin M, Chen X, et al. Efficacy of
empowerment strategies for patients with hypertension: A
systematic review and meta-analysis. Vol. 103, Patient
Education and Counseling. Elsevier Ireland Ltd; 2020. p. 898–
907. https://doi.org/10.1016/j.pec.2019.11.025
[2] Mills KT, Stefanescu A, He J. The global epidemiology of
hypertension. Vol. 16, Nature Reviews Nephrology. Nature
Research; 2020. p. 223–37. https://doi.org/10.1038/s41581-
019-0244-2
[3] Unger T, Borghi C, Charchar F, Khan NA, Poulter NR,
Prabhakaran D, et al. 2020 International Society of
Hypertension Global Hypertension Practice Guidelines.
Hypertension. 2020;75(6):1334–57.
https://doi.org/10.1161/HYPERTENSIONAHA.120.15026
[4] Ageing and health [Internet]. 2025 [cited 2025 Nov 25].
Available from: https://www.who.int/news-room/factsheets/detail/ageing-and-health
[5] Riswanto MI, Cholisoh Z. Assessment of Potentially
Inappropriate Medication (PIMs) in Older Adult Patients at The
Geriatric Polyclinic of a General Hospital in Central Java. Jurnal
Ilmu Kesehatan. 2023;11(2).
[6] Aggarwal P, Woolford SJ, Patel HP. Multi-morbidity and
polypharmacy in older people: Challenges and opportunities
for clinical practice. Vol. 5, Geriatrics (Switzerland).
Multidisciplinary Digital Publishing Institute (MDPI); 2020.
https://doi.org/10.3390/geriatrics5040085
[7] Maher RL, Hanlon J, Hajjar ER. Clinical consequences of
polypharmacy in elderly. Vol. 13, Expert Opinion on Drug
Safety. 2014. p. 57–65.
https://doi.org/10.1517/14740338.2013.827660
[8] Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is
polypharmacy? A systematic review of definitions. BMC
Geriatr. 2017;17(1):1–10. https://doi.org/10.1186/S12877-
017-0621-2/TABLES/1
[9] Ngcobo NN. Influence of Ageing on the Pharmacodynamics
and Pharmacokinetics of Chronically Administered Medicines
in Geriatric Patients: A Review. Clinical Pharmacokinetics 2025
64:3. 2025;64(3):335–67. https://doi.org/10.1007/S40262-
024-01466-0
[10] Zazzara MB, Palmer K, Vetrano DL, Carfì A, Graziano O. Adverse
drug reactions in older adults: a narrative review of the
literature. Eur Geriatr Med. 2021;12(3):463–73.
https://doi.org/10.1007/S41999-021-00481-9
[11] Mashuri YA, Ng N, Santosa A. Socioeconomic disparities in the
burden of hypertension among Indonesian adults - a multilevel
analysis. Glob Health Action. 2022;15(1).
https://doi.org/10.1080/16549716.2022.2129131
[12] Maharani P, Kumalasari I, Author C. EPIDEMIOLOGICAL
JOURNAL OF INDONESIA DETERMINANT FACTORS OF
HYPERTENSION IN THE ELDERLY AT PUBLIC HEALTH CENTER IN
PALEMBANG, SOUTH SUMATERA INDONESIA. Vol. 2. 2023.
[13] Alwhaibi M. Potentially Inappropriate Medications Use among
Older Adults with Comorbid Diabetes and Hypertension in an
Ambulatory Care Setting. J Diabetes Res. 2022;2022.
https://doi.org/10.1155/2022/1591511
[14] American Geriatrics Society 2023 updated AGS Beers Criteria®
for potentially inappropriate medication use in older adults. J
Am Geriatr Soc. 2023;71(7):2052–81.
https://doi.org/10.1111/jgs.18372
[15] Tian F, Chen Z, Zeng Y, Feng Q, Chen X. Prevalence of Use of
Potentially Inappropriate Medications Among Older Adults
Worldwide: A Systematic Review and Meta-Analysis. JAMA
Netw Open. 2023;6(8):e2326910.
https://doi.org/10.1001/JAMANETWORKOPEN.2023.26910
[16] Widyaningrum DA, Rahmadi M, Hamidah KF, Aminde LN,
Nugroho CW, Zulkarnain BS. Polypharmacy as the risk factor of
potentially inappropriate medication and medication regimen
complexity index in hospitalised elderly patients. Pharmacy
Education. 2023;23(4):325–30.
https://doi.org/10.46542/pe.2023.234.325330
[17] Abdulah R, Insani WN, Destiani DP, Rohmaniasari N,
Mohenathas ND, Barliana MI. Polypharmacy leads to increased
prevalence of potentially inappropriate medication in the
Indonesian geriatric population visiting primary care facilities.
Ther Clin Risk Manag. 2018;14:1591.
https://doi.org/10.2147/TCRM.S170475
[18] Mulyani T, Rukminingsih F. EVALUASI PERESEPAN PADA
PASIEN GERIATRI DI KLINIK PENYAKIT DALAM INSTALASI
RAWAT JALAN RSUD K.R.M.T WONGSONEGORO SEMARANG.
Vol. 2. 2020.
[19] Nurmainah N, Astuti R. Detection of Potentially Inappropriate
Medication in Elderly Outpatient Based on The Beer’s Criteria
2019. JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA.
2022;9(1):82–91. https://doi.org/10.20473/jfiki.v9i12022.82-
91
[20] Nurhasnah N, Viviandhari D, Sakinah RN, Wulandari D.
Potentially Inappropriate Medication (PIMs) Identification
Using 2019 Beers Criteria at a Secondary Referral Hospital in
Jakarta. JURNAL MANAJEMEN DAN PELAYANAN FARMASI
(Journal of Management and Pharmacy Practice).
2022;12(3):153. https://doi.org/10.22146/jmpf.71246
[21] Cockcroft-Gault Formula | National Kidney Foundation
[Internet]. 2025 [cited 2025 Dec 22]. Available from:
https://www.kidney.org/professionals/gfr_calculatorCoc
[22] Wang BX. Diagnosis and Management of Hypertensive Heart
Disease: Incorporating 2023 European Society of Hypertension
and 2024 European Society of Cardiology Guideline Updates. J
Cardiovasc Dev Dis. 2025;12(2):46.
https://doi.org/10.3390/JCDD12020046
[23] Ananchaisarp T, Chamroonkiadtikun P, Kodchakrai K, Saeung
T, Charatcharungkiat T, Leelarujijaroen P, et al. Prevalence of
potentially inappropriate medication among older patients in
a primary care unit of a tertiary care hospital in Thailand: A
retrospective cross-sectional study. BMJ Open . 2025;15(5).
https://doi.org/10.1136/BMJOPEN-2024-091465
[24] Karki S, Thapa RB, Shrestha R. Exploring Potentially
Inappropriate Medication Use on Elderly Patients in a General
Medicine Ward Using 2023 AGS Beers Criteria. Aging Medicine.
2025;8(3):238–48. https://doi.org/10.1002/agm2.70025
[25] Chang CT, Chan HK, Tan AY, Kamis SF, Yeo YL, Azman MA, et al.
Comparing Beers, STOPP and MALPIP criteria in detecting
potentially inappropriate medications, clinical outcomes, and
cost impacts among older Malaysians: a cohort study. J Pharm
Policy Pract. 2024;17(1):2436896.
https://doi.org/10.1080/20523211.2024.2436896
Potentially Inappropriate Medications (PIMs) in … Issa et al.
Jurnal Sains Farmasi & Klinis | Vol. 13 No. 01 | 2026 45
[26] Vukoja M, Mimica S. Comparison of explicit criteria for
potentially inappropriate drug prescribing among the elderly:
a narrative review. Discover Health Systems 2024 3:1.
2024;3(1):62-. https://doi.org/10.1007/S44250-024-00102-9
[27] Zhu X, Zhang F, Zhao Y, Zhang W, Zhang Y, Wang J. Evaluation
of potentially inappropriate medications for the elderly
according to beers, STOPP, START, and Chinese criteria. Front
Pharmacol. 2023;14:1265463.
https://doi.org/10.3389/FPHAR.2023.1265463/BIBTEX
[28] Herrero Domínguez-Berrueta MC, Muñoz-García M, Delgado Silveira E, Martín-Aragón S, Gangoso Fermoso A. Primary care
pharmacist-led medication review in older adult patients in
coordination with general practitioners: an observational
retrospective cohorts study. Exploratory Research in Clinical
and Social Pharmacy. 2024;13:100390.
https://doi.org/10.1016/J.RCSOP.2023.100390
[29] McGrory F, Elnaem MH. Pharmacist-Led Interventions for
Polypharmacy Management in Older Adults: A Systematic
Review of Strategies and Outcomes in the United Kingdom and
the Republic of Ireland. Pharmacy. 2025;13(4):109.